Meridien Research Tampa Bay - Clinical Studies Tampa

Meridien Research - An Independent Medical Research Company

Tampa Clinical Studies

The Tampa office of Meridien Research is currently conducting research studies in the following areas:

·        Gout

·        Multiple Sclerosis

·        Smoking Cessation

Coming Soon:

African American Type II Diabetes
Depression
Fibromyalgia
High Cholesterol

Call

813-877-8839

for more details

New studies are added continually.

Please call our office to speak to a medical professional

about study details or new studies offered.

Gout

Gout flare-ups? Pain, swelling and tenderness in your joints? If you are experiencing these symptoms and are at least 18-years of age you may qualify to participate in a clinical research study. Call Meridien Research at 813-877-8839.

Multiple Sclerosis #1

Do you have Multiple Sclerosis? Meridien Research is conducting an investigational medication research study for individuals who have relapsing Multiple Sclerosis. This study includes:

•   Oral Investigational Medication or Placebo (inactive look-alike pill)
•   Laboratory tests
•   Compensation for time and travel up to $810.00
•   Study related physician visits

Cynthia Huffman, MD is a board certified Neurologist specializing in the treatment of Multiple Sclerosis. If you or someone you know is interested in finding out more about this study, please call Meridien Research 813-877-8839.

Multiple Sclerosis #2

Have you been diagnosed with Multiple Sclerosis? Do you suffer from relapses? You may be eligible to participate in a clinical research study up to 2 years to determine the safety and efficacy of an investigational medication in slowing the progression and decreasing the relapse rate in MS patients. Participants will receive study related medication and study related medical care. Medical insurance is not necessary to participate in this trial.

Interested participants should call Meridien Research today at 813-877-8839. Or visit us on the web at www.newstudyinfo.com.

Compensation for time and travel may be available

Multiple Sclerosis #3

New MS Study Offers Hope of Less Injections

Meridien Research is currently conducting a clinical research study to test the efficacy and safety of a higher dose of Glatiramer Acetate (Copaxone®), given less frequently vs. a placebo. Glatiramer Acetate (Copaxone®), is approved to reduce the frequency of relapses in patients with relapsing-remitting MS. The dose used in this study is higher than the approved dose and is therefore investigational. Participants ages 18-55 will receive study-related medication or placebo for the duration of the study. Study-related medical care and three MRIs are included as part of the study. No medical insurance is necessary to participate. Compensation may be available for time and travel. Call 813-87-STUDY.

Smoking Cessation

Looking to stop smoking? Consider joining our Smoking Cessation Study.

We are enrolling volunteers in a clinical trial to study the effects of NicVAX, an investigational nicotine vaccine as an aid to stop smoking vs. a placebo. If you’ve smoked an average of at least 10 cigarettes day for the last year and are between the ages of 18-65 you may qualify for this research study. You must be able to make a 1 year commitment to enroll in this study. Participants may receive study related medication and study related medical care. Medical insurance is not necessary.

Compensation for time and travel may be available.

Call Meridien Research at 813-877-8839 for more information.

top